Skip to main content

Corient Private Wealth LLC

Position in NVS — Novartis AG

CIK 1948780 MIAMI, FL

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$67,290,346
+$1,125,982 QoQ
Shares Held
440,526
-8.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 54.047457158332655.ToString("F0")% Shared 1.0208244500017287.ToString("F0")% None 44.93171839166561.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $2,531,352,954 across 16 Drug Manufacturers - General names. NVS ranks #8 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
440,526 $67,290,346

All Filings in NVS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $67,290,346 440,526
2025-12-31 $66,164,364 479,904
2025-09-30 $58,803,168 458,540
2025-06-30 $54,796,109 452,823
2025-03-31 $51,624,157 463,080
2024-12-31 $52,696,088 541,528
2024-09-30 $66,687,675 579,792
2024-06-30 $61,824,834 580,733
2024-03-31 $56,663,273 585,788
2023-12-31 $59,326,235 587,563
2023-09-30 $46,650,351 457,985
2023-06-30 $45,848,559 454,351
2023-03-31 $37,115,652 403,431
2022-12-31 $23,304,697 256,886